Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

VPI-2690B

😃Good
Catalog No. T9901A-1664

VPI-2690B is a human-derived monoclonal antibody (mAb) that targets Integrin αVβ3. It is capable of modulating TGF-β signaling and can be utilized in research related to diabetic nephropathy.

VPI-2690B

VPI-2690B

😃Good
Catalog No. T9901A-1664
VPI-2690B is a human-derived monoclonal antibody (mAb) that targets Integrin αVβ3. It is capable of modulating TGF-β signaling and can be utilized in research related to diabetic nephropathy.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
VPI-2690B is a human-derived monoclonal antibody (mAb) that targets Integrin αVβ3. It is capable of modulating TGF-β signaling and can be utilized in research related to diabetic nephropathy.
Chemical Properties
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy VPI-2690B | purchase VPI-2690B | VPI-2690B cost | order VPI-2690B